Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.
about
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesDietary fat intake and ovarian cancer risk: a meta-analysis of epidemiological studiesClear cell carcinoma of the ovary: is there a role of histology-specific treatment?ARID1A gene silencing reduces the sensitivity of ovarian clear cell carcinoma to cisplatinFertility-sparing surgery for early stage epithelial ovarian cancer.Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression.Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary.Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas.X-chromosome-linked inhibitor of apoptosis as a key factor for chemoresistance in clear cell carcinoma of the ovary.DNA copy numbers profiles in affinity-purified ovarian clear cell carcinomaThe tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylationExpression of mitochondrial regulators PGC1α and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinomaRsf-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma.Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor developmentMicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cellsSomatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinomaDefective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach.Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary.Ovarian clear cell adenocarcinoma: a continuing enigmaClinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.Modulation of estrogenic action in clear cell carcinoma of the ovary (Review).Ovarian clear cell carcinoma, outcomes by stage: the MSK experience.Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review.Methoxyphenyl chalcone sensitizes aggressive epithelial cancer to cisplatin through apoptosis induction and cancer stem cell eradication.Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.Current status and implications of microRNAs in ovarian cancer diagnosis and therapy.Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.Clear cell histology as a poor prognostic factor for advanced epithelial ovarian cancer: a single institutional case series through central pathologic reviewTelomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.Genetic and molecular changes in ovarian cancer.Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma.New hypothesis on pathogenesis of ovarian cancer lead to future tailored approaches.Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.Critical molecular abnormalities in high-grade serous carcinoma of the ovary.Effect of ARID1A/BAF250a expression on carcinogenesis and clinicopathological factors in pure-type clear cell adenocarcinoma of the ovary.Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.Two cases of clear cell ovarian cancer in young patients.
P2860
Q21563402-106640A2-BFDD-462A-B6E7-E4291B3A8CB2Q26749395-2FEA8117-8DAE-4B11-9A76-B988C3786743Q27012348-533096AD-4A7A-45A1-BDC2-2FF5455BE5FFQ28468340-8CCF7147-5AC9-4E2F-A545-A371C04D3F08Q30249715-CFBF4D48-6158-428E-B830-16CDC109264AQ33355350-09AF004B-1C80-4EA2-98C8-F6B6C52628FAQ33362731-CA9DFFF2-8448-4405-8B7E-129EC8394659Q33363736-0C2AECD9-0994-4401-8FAC-50820A9EFE3BQ33563929-76221E2B-0302-4440-BC3B-577B2D5F04D1Q33750177-CD1CC685-4F9C-4EC1-9167-1876FFEDA524Q33767047-CD52547C-048D-447C-B614-313C3DC1C526Q34029565-D1E664FD-3A27-403F-9CEC-1FF466FCD8A5Q34223682-C3AA298E-9678-4541-B91F-5BAF9ECA3866Q34643587-0F69B305-E751-4A37-8066-0192D81935E5Q34771886-CECFCF32-DF4A-4A66-9768-2CE576973F6AQ34896728-33C3AB38-D55D-4756-9A2A-D4649F35F0B7Q35051543-CDB94022-CB53-4F1B-B30D-19A8319953DCQ35057812-8008D43F-7021-48E1-80E3-DCC6C255149AQ35612005-DF105006-9F16-4475-A9BD-E93512672700Q35870176-FE0E2BC6-099A-4312-BD60-C07E4EF1D045Q36026090-42EE2EC4-D620-4848-A2E2-6BB66847B8ECQ36178605-E2F8184F-FB6F-451C-8230-652F8E512FA4Q36224720-B29F2679-09C3-45BF-BD25-3CE78CF14493Q36246203-0494C19D-3A80-4F37-8262-35C38FCD4237Q36288013-3D54F540-FDB3-461C-9366-3496EECE1C43Q36361670-8147C464-4D58-4ACA-A17A-3554C34B2B9BQ36469640-779355FC-CC87-4ABE-A6C6-461F5524C231Q36517492-B2854BFF-1658-457D-BAE3-B1C48169D99EQ36529643-3DDE193E-7AEC-481E-9258-FF79464CAA47Q36547025-EE8BCD02-D662-4DAB-8F02-0DEDF6240E3CQ36608043-84A285CB-D7DD-496D-927D-BD65E7FCBE7AQ37094076-3BA21D7E-81C3-4E21-8FF5-77BD0E454883Q37145551-6C0CC169-8EED-4D23-B017-37B189A90953Q37155964-E44E3B68-E28A-411C-BA06-A19ED981E4DAQ37164133-B2E5A68F-74EB-461D-B484-3E4A6CC1F980Q37225222-50BF7761-1E71-4869-915A-E945D6D0DDEDQ37232123-2E3EC802-0043-4637-8D8A-14FCFDBB1618Q37287587-54C1BA1A-3830-460D-9BB6-B215967C1B1CQ37296914-0A3862F4-46AF-410D-9CEE-FB21DE6F131BQ37335723-C2277EAE-4FD8-4BA2-A439-7276B1FFD42D
P2860
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Clear cell carcinoma of the ov ...... ith complete surgical staging.
@ast
Clear cell carcinoma of the ov ...... ith complete surgical staging.
@en
type
label
Clear cell carcinoma of the ov ...... ith complete surgical staging.
@ast
Clear cell carcinoma of the ov ...... ith complete surgical staging.
@en
prefLabel
Clear cell carcinoma of the ov ...... ith complete surgical staging.
@ast
Clear cell carcinoma of the ov ...... ith complete surgical staging.
@en
P2093
P2860
P356
P1476
Clear cell carcinoma of the ov ...... with complete surgical staging
@en
P2093
N Yaegashi
T Sugiyama
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603116
P407
P577
2006-05-01T00:00:00Z